Twitter Goes All-In on Long-Form Content with Revue

On today’s episode of MarketScale TV, Voice of B2B Daniel Litwin sits down with Joe Sinkwitz, founder and CEO of Intellifluence, to give analysis on Twitter’s official acquisition of newsletter platform Revue and whether the hopes to bring more writers and publishers to the Twitter content ecosystem will pay off.

Revue has become a popular platform for long-form content creators, where thought leaders and journalists can grow a following over email rather than compete on social media sites. It boasts subscription-based business model, with a free version that lets writers send newsletters to up to 50 people, and a paid version that lets them email up to 40,000 people.

Over the years, Twitter has slowly made moves to distance itself from its original 140-character format, but acquiring Revue marks the sites first full attempt to get into the long-from content space.

In a statement, Product Lead Kayvon Beykpour and VP of Publisher Products Mike Park said Revue’s existing base of writers were going to be a “valuable part of the conversation and it’s critical we offer new ways for them to create and share their content, and importantly, help them grow and better connect with their audience.”

As for how the acquisition will change the nature of Twitter as a social media offering, Beykpour and Park framed it as a deal that will “help people stay informed about their interests while giving all types of writers a way to monetize their audience – whether it’s through the one they built at a publication, their website, on Twitter, or elsewhere.”

Sinkwitz & Litwin break down whether this is a positive strategic move for Twitter, how Twitter’s audience will change, how this sets up Twitter to compete against other social media companies and content curation platforms, and whether this move indicates anything about the viability of short-form social media content moving forward.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More